RecruitingNCT05664516
Nasal oxytocin or placebo for adults with binge-eating episodes
About this title
A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder
Read the official source — NCT05664516Medication studyAges 18–70United StatesEating disorders
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
What will I do during this study?
Participants use an oxytocin nasal spray or placebo (an inactive comparison treatment) for eight weeks. The study measures appetite, reward sensitivity and impulse control at week 4 and clinical outcomes at week 8.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Treatment duration
- The nasal-spray treatment lasts eight weeks
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 7, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT05664516
- Official title
Show the full official title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Intranasal Oxytocin in Adults With Binge-eating Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including TNX-1900 (Tonix Pharmaceuticals) and Placebo.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
